Injection to control diabetes without side effects

Image
IANS New York
Last Updated : Jul 17 2014 | 2:42 PM IST

Dealing with diabetes could soon be a lot easier as researchers have developed an injection that can restore blood sugar levels to normal for more than two days without any side effects.

In mice with diet-induced diabetes - the equivalent of type-2 diabetes in humans - a single injection of the protein FGF1 was found enough to control blood sugar levels.

"FGF1 offers a new method to control glucose in a powerful and unexpected way," said Ronald Evans from Salk Institute for Biological Studies in the US.

The discovery could lead to a new generation of safer, more effective diabetes drugs.

Sustained treatment with the protein does not merely keep blood sugar under control, but also reverses insulin insensitivity, the underlying physiological cause of diabetes, the findings showed.

Equally exciting, the newly developed treatment did not result in side effects common to most current diabetes treatments.

For the study, researchers injected doses of FGF1 into obese mice with diabetes to assess the protein's potential impact on metabolism.

They found that with a single dose, blood sugar levels quickly dropped to normal levels in all the diabetic mice.

"Many previous studies that injected FGF1 showed no effect on healthy mice," said Michael Downes, a senior staff scientist at Salk Institute.

"However, when we injected it into a diabetic mouse, we saw a dramatic improvement in glucose levels," Downes added.

The study appeared in the journal Nature.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 17 2014 | 2:34 PM IST

Next Story